The era of securing high-multiplier valuations in the medical technology sector based solely on regulatory clearances or early clinical trial data has drawn to a close. This strategic market analysis examines how venture capital and private equity firms are fundamentally reshaping their investment criteria to prioritize real commercial traction and scalable market adoption. Learn how ... https://www.sganalytics.com/blog/medtech-vc-pe-trends-commercial-traction/